IL13 and neoplasm: In contrast, IL-4/IL-13 stimulation promotes the M2 phenotype that is characterized by the upregulated expression of arginase 1 (Arg1), which metabolizes L-arginine to various tumor-supporting factors (e.g., L-ornithine and polyamines) [29,30,31].